Found 38 matching trials
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis PHASE2 This phase II trial studies how well radiation therapy given with standard ...
Show More Location
Grady Health System
Learn More & Join Trial
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer PHASE2 This phase II trial studies the side effects and how well palbociclib and l...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Study of PF-07248144 in Advanced or Metastatic Solid Tumors PHASE2 This is an open-label, multi center study to evaluate safety, tolerability,...
Show More Learn More & Join Trial
Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer PHASE3 POLAR is a phase III clinical trial, which will test the safety and efficac...
Show More Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Learn More & Join Trial
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer PHASE3 Given the uncertain benefit in efficacy of adding CDK 4/6 to first rather t...
Show More Status
Active Not Recruiting
Location
Jeroen Bosch Ziekenhuis
Learn More & Join Trial
SMMART Adaptive Clinical Treatment (ACT) Trial EARLY_PHASE1 SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Show More Location
Multiple Locations
Learn More & Join Trial
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer PHASE1 This is an open-label, multicenter, Phase I study designed to evaluate the ...
Show More Status
Active Not Recruiting
Location
Massachusetts General Hospital.
Learn More & Join Trial
Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer PHASE2 This is an international, randomized, open-label, controlled, multicenter p...
Show More Location
MedSIR investigative site
Learn More & Join Trial
PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) PHASE2 Hormone Receptor (HR)-positive/Human Epidermal Growth Factor Receptor 2 (HE...
Show More Location
Hôpital Jean Minjoz
Learn More & Join Trial
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation, the INTERACT Study PHASE2 This phase II trial studies how well letrozole, anastrozole, or fulvestrant...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial